Will Lilly Hit $750 Tonight After Earnings Beats?

Eli Lilly jumps 5% in pre-hour trading after it reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro. Eli Lilly gained 61% last year and this year, the trend has continued, with the stock up by 15% since the start of 2024. --------------------- How do you view LLY's earnings? At what price will you buy the weight loss producer?

+ Follow

Mangoman

02-07

[Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile]

DavidMarlin

02-07

NVDA could see upside to $1100+

$NVIDIA Corp(NVDA)$ could see upside to $1100+ if it continues mirroring the trajectory of $Cisco(CSCO)$ during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1

NVDA could see upside to $1100+

DaisyMoore

02-06

$Eli Lilly(LLY)$ This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.

KarenAldridge

02-06

$Eli Lilly(LLY)$ You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.

PorterLamb

02-06

$Eli Lilly(LLY)$ I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.

MurrayBulwer

02-06

$Eli Lilly(LLY)$ I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.

MamieBenson

02-06

$Eli Lilly(LLY)$ LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.

Warrior388

02-06

Yes, no doubt of it, another nvda in phama sector.

NAI500

02-04

Can Novavax help investors become millionaires?

图片$Novavax(NVAX)$ stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp

Can Novavax help investors become millionaires?

TigerGPT

02-03

Q: What is Eli Lilly 2023/Q4 Earnings Preview?

TigerGPT Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve

Q: What is Eli Lilly 2023/Q4 Earnings Preview?

NAI500

02-02

Amgen - a premium healthcare dividend stock with stable cash flow

Compared to other dividend stocks like REITs, the dividend yield from a company like $Amgen(AMGN)$ might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, $Amgen(AMGN)$ is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s

Amgen - a premium healthcare dividend stock with stable cash flow

Capital_Insights

02-01

Healthcare Giants NVO & LLY Eye Trillion-Dollar Club

The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp

Healthcare Giants NVO & LLY Eye Trillion-Dollar Club

TrendSpider

01-31

Trend Charts: GOOG, PYPL, ARKK, LLY, BABA, AMD& TSLA

Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for $Costco(COST)$ as price cracks the $700 mark... When stock split?ImageARK Innovation Update $ARK Innovation ETF(ARKK)$ Cathie Wood now owns $615M of $Tesla Motors(TSLA)$ in the $ARK Innovation ETF(ARKK)$ ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image $PayPal(PYPL)$ flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image

Trend Charts: GOOG, PYPL, ARKK, LLY, BABA, AMD& TSLA

Value_investing

01-29

Lilly becomes the winner when investors turns to weight loss drugs

图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, $Tesla Motors(TSLA)$ 's market value has lost $80 billion, so $Eli Lilly(LLY)$ 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges

Lilly becomes the winner when investors turns to weight loss drugs

Twelve_E

01-24

$LLY could be the first trillion-dollar healthcare stock

The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the "trillion-dollar club" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: $Eli Lilly(LLY)$ leads the pack with a market cap of $610 billion, followed by health care giant $UnitedHealth(UNH)$ with a market capitalization of about $482 billion, And the $470 billion Danish drug

$LLY could be the first trillion-dollar healthcare stock

{"data":{"themeId":"985f61b587a64fe0a07e77ca854c585f","name":"Will Lilly Hit $750 Tonight After Earnings Beats?","description":"Eli Lilly jumps 5% in pre-hour trading after it reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro.\nEli Lilly gained 61% last year and this year, the trend has continued, with the stock up by 15% since the start of 2024.\n---------------------\nHow do you view LLY's earnings?\nAt what price will you buy the weight loss producer?","image":"https://community-static.tradeup.com/news/12d1e2d049a424147b0f584cda6a80fe","type":0,"style":1,"follow":false,"createTime":1707122564310,"userCounts":1,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":985f61b587a64fe0a07e77ca854c585f}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":true,"hasReward":true,"rewardScore":2000,"rewardValidDate":1707381757000,"rewardEnd":true,"symbols":[],"tweetCounts":17,"categoryId":"7a15628ce2174325bddc6229505e0d70","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"Will Lilly Hit $750 Tonight After Earnings Beats?","tweetAmount":17,"imageIsDefault":false},"tab":"all","allList":[{"id":271266406834384,"gmtCreate":1707265059399,"gmtModify":1707265064283,"author":{"id":"4165616159265732","authorId":"4165616159265732","name":"Mangoman","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;&nbsp;","text":"[Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271266406834384","isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271320697122824,"gmtCreate":1707265016503,"gmtModify":1707271656380,"author":{"id":"4120382896042882","authorId":"4120382896042882","name":"DavidMarlin","avatar":"https://community-static.tradeup.com/news/4f415c3ff5550e60135034b2936557a9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"NVDA could see upside to $1100+","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$</a> could see upside to $1100+ if it continues mirroring the trajectory of <a href=\"https://ttm.financial/S/CSCO\">$Cisco(CSCO)$</a> during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$</a> could see upside to $1100+ if it continues mirroring the trajectory of <a href=\"https://ttm.financial/S/CSCO\">$Cisco(CSCO)$</a> during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","text":"$NVIDIA Corp(NVDA)$ could see upside to $1100+ if it continues mirroring the trajectory of $Cisco(CSCO)$ during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","images":[{"img":"https://community-static.tradeup.com/news/92db78f6c26b912544295d46418a99ff","width":"1918","height":"1147"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/271320697122824","isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},{"id":271068527988744,"gmtCreate":1707203451772,"gmtModify":1707204068162,"author":{"id":"9000000000000640","authorId":"9000000000000640","name":"DaisyMoore","avatar":"https://static.tigerbbs.com/0b6d4586dc3002807c92bc57e1b3a6bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","text":"$Eli Lilly(LLY)$ This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068527988744","isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271068694966288,"gmtCreate":1707203393539,"gmtModify":1707203396671,"author":{"id":"9000000000000524","authorId":"9000000000000524","name":"KarenAldridge","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","text":"$Eli Lilly(LLY)$ You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068694966288","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271068192170000,"gmtCreate":1707203270786,"gmtModify":1707203274164,"author":{"id":"9000000000000420","authorId":"9000000000000420","name":"PorterLamb","avatar":"https://static.tigerbbs.com/9c61226b13dc84ab3139a9fa00b20782","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","text":"$Eli Lilly(LLY)$ I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068192170000","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271067102011400,"gmtCreate":1707203103633,"gmtModify":1707203107483,"author":{"id":"9000000000000463","authorId":"9000000000000463","name":"MurrayBulwer","avatar":"https://static.tigerbbs.com/86339b64cf42eeac7905c45fdbbed7fb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","text":"$Eli Lilly(LLY)$ I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271067102011400","isVote":1,"tweetType":1,"viewCount":31,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271067166711824,"gmtCreate":1707203020430,"gmtModify":1707203027192,"author":{"id":"9000000000000494","authorId":"9000000000000494","name":"MamieBenson","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","text":"$Eli Lilly(LLY)$ LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","images":[{"img":"https://community-static.tradeup.com/news/a0eff104dcee9b096d48ca67e5d92cef","width":"367","height":"300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271067166711824","isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":270882760790256,"gmtCreate":1707171457450,"gmtModify":1707171462512,"author":{"id":"3579087512632846","authorId":"3579087512632846","name":"Warrior388","avatar":"https://static.tigerbbs.com/51833ad468f8a1ea4c6681fe3c76c453","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Yes, no doubt of it, another nvda in phama sector.","listText":"Yes, no doubt of it, another nvda in phama sector.","text":"Yes, no doubt of it, another nvda in phama sector.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/270882760790256","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":270470812565520,"gmtCreate":1707057426156,"gmtModify":1707132076751,"author":{"id":"4144906086863692","authorId":"4144906086863692","name":"NAI500","avatar":"https://community-static.tradeup.com/news/01a5cfb1c65c21d31f28a3934107c034","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Can Novavax help investors become millionaires?","htmlText":"图片<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","listText":"图片<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","text":"图片$Novavax(NVAX)$ stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","images":[{"img":"https://community-static.tradeup.com/news/0b9d779cc9ff4b8158915ee5f25df5c1","width":"902","height":"557"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/270470812565520","isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":269908004597776,"gmtCreate":1706920021867,"gmtModify":1707122633476,"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Q: What is Eli Lilly 2023/Q4 Earnings Preview?","htmlText":"<a href=\"https://ttm.financial/gpt\">TigerGPT</a> Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","listText":"<a href=\"https://ttm.financial/gpt\">TigerGPT</a> Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","text":"TigerGPT Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/269908004597776","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":269729708081168,"gmtCreate":1706876492444,"gmtModify":1707122633604,"author":{"id":"4144906086863692","authorId":"4144906086863692","name":"NAI500","avatar":"https://community-static.tradeup.com/news/01a5cfb1c65c21d31f28a3934107c034","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Amgen - a premium healthcare dividend stock with stable cash flow","htmlText":"Compared to other dividend stocks like REITs, the dividend yield from a company like <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","listText":"Compared to other dividend stocks like REITs, the dividend yield from a company like <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","text":"Compared to other dividend stocks like REITs, the dividend yield from a company like $Amgen(AMGN)$ might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, $Amgen(AMGN)$ is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","images":[{"img":"https://community-static.tradeup.com/news/a23f302bf567521fec5d27e46a04ef6d","width":"560","height":"240"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":488,"commentSize":4,"repostSize":48,"link":"https://ttm.financial/post/269729708081168","isVote":1,"tweetType":1,"viewCount":2802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":269377699418120,"gmtCreate":1706790651828,"gmtModify":1707122633500,"author":{"id":"3527667668165440","authorId":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Healthcare Giants NVO & LLY Eye Trillion-Dollar Club","htmlText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","listText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","text":"The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","images":[{"img":"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e","width":"1540","height":"705"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":472,"commentSize":2,"repostSize":72,"link":"https://ttm.financial/post/269377699418120","isVote":1,"tweetType":1,"viewCount":2628,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274781763777","authorId":"3479274781763777","name":"tothehill","avatar":"https://static.laohu8.com/picture118","crmLevel":1,"crmLevelSwitch":0},"content":"Hilarious market potential! 😂 Agree! 🙌","text":"Hilarious market potential! 😂 Agree! 🙌","html":"Hilarious market potential! 😂 Agree! 🙌"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":268946265260032,"gmtCreate":1706681476872,"gmtModify":1707122633559,"author":{"id":"9000000000000369","authorId":"9000000000000369","name":"TrendSpider","avatar":"https://community-static.tradeup.com/news/735481e1e3ac7d7e59d7f9448b31b8a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Trend Charts: GOOG, PYPL, ARKK, LLY, BABA, AMD& TSLA","htmlText":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for <a href=\"https://ttm.financial/S/COST\">$Costco(COST)$</a> as price cracks the $700 mark... When stock split?ImageARK Innovation Update <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> Cathie Wood now owns $615M of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> in the <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image <a href=\"https://ttm.financial/S/PYPL\">$PayPal(PYPL)$</a> flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","listText":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for <a href=\"https://ttm.financial/S/COST\">$Costco(COST)$</a> as price cracks the $700 mark... When stock split?ImageARK Innovation Update <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> Cathie Wood now owns $615M of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> in the <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image <a href=\"https://ttm.financial/S/PYPL\">$PayPal(PYPL)$</a> flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","text":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for $Costco(COST)$ as price cracks the $700 mark... When stock split?ImageARK Innovation Update $ARK Innovation ETF(ARKK)$ Cathie Wood now owns $615M of $Tesla Motors(TSLA)$ in the $ARK Innovation ETF(ARKK)$ ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image $PayPal(PYPL)$ flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","images":[{"img":"https://community-static.tradeup.com/news/c0659081d0a154c848a2a2c54aabe504","width":"1128","height":"726"},{"img":"https://community-static.tradeup.com/news/a5815dcd968bfb6df3ce5e56347217b1","width":"1128","height":"726"},{"img":"https://community-static.tradeup.com/news/1151b1f125124a4ecea022537e66aa29","width":"1128","height":"726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":52,"commentSize":1,"repostSize":3,"link":"https://ttm.financial/post/268946265260032","isVote":1,"tweetType":1,"viewCount":1766,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274777284002","authorId":"3479274777284002","name":"uuunited","avatar":"https://static.laohu8.com/picture108","crmLevel":1,"crmLevelSwitch":0},"content":"LOL, I agree with the potential stocks! 🚀","text":"LOL, I agree with the potential stocks! 🚀","html":"LOL, I agree with the potential stocks! 🚀"}],"imageCount":8,"langContent":"EN","totalScore":0},{"id":268303618764872,"gmtCreate":1706523464890,"gmtModify":1707122633525,"author":{"id":"3527667626267411","authorId":"3527667626267411","name":"Value_investing","avatar":"https://community-static.tradeup.com/news/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Lilly becomes the winner when investors turns to weight loss drugs","htmlText":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> 's market value has lost $80 billion, so <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","listText":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> 's market value has lost $80 billion, so <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","text":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, $Tesla Motors(TSLA)$ 's market value has lost $80 billion, so $Eli Lilly(LLY)$ 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","images":[{"img":"https://community-static.tradeup.com/news/5bba35399199a6abee026b7770fe78a9","width":"719","height":"461"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":66,"commentSize":1,"repostSize":7,"link":"https://ttm.financial/post/268303618764872","isVote":1,"tweetType":1,"viewCount":769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":266562335506688,"gmtCreate":1706110721909,"gmtModify":1707122633582,"author":{"id":"4100909900193040","authorId":"4100909900193040","name":"Twelve_E","avatar":"https://static.tigerbbs.com/cfe7691e5de91fdc66dd91dd80b1207c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"$LLY could be the first trillion-dollar healthcare stock","htmlText":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> leads the pack with a market cap of $610 billion, followed by health care giant <a href=\"https://ttm.financial/S/UNH\">$UnitedHealth(UNH)$</a> with a market capitalization of about $482 billion, And the $470 billion Danish drug","listText":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> leads the pack with a market cap of $610 billion, followed by health care giant <a href=\"https://ttm.financial/S/UNH\">$UnitedHealth(UNH)$</a> with a market capitalization of about $482 billion, And the $470 billion Danish drug","text":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: $Eli Lilly(LLY)$ leads the pack with a market cap of $610 billion, followed by health care giant $UnitedHealth(UNH)$ with a market capitalization of about $482 billion, And the $470 billion Danish drug","images":[{"img":"https://community-static.tradeup.com/news/2a361d23ecf16ad5423ccee7ca5a7b43","width":"1280","height":"720"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":2189,"commentSize":5,"repostSize":644,"link":"https://ttm.financial/post/266562335506688","isVote":1,"tweetType":1,"viewCount":15771,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4087650318161980","authorId":"4087650318161980","name":"ahBern","avatar":"https://static.tigerbbs.com/88263929bb1a9cc8c5ea90409c5bd436","crmLevel":3,"crmLevelSwitch":1},"content":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","html":"Great ariticle, would you like to share it?"}],"imageCount":2,"langContent":"EN","totalScore":0}],"essenList":[{"id":266562335506688,"gmtCreate":1706110721909,"gmtModify":1707122633582,"author":{"id":"4100909900193040","authorId":"4100909900193040","name":"Twelve_E","avatar":"https://static.tigerbbs.com/cfe7691e5de91fdc66dd91dd80b1207c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"$LLY could be the first trillion-dollar healthcare stock","htmlText":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> leads the pack with a market cap of $610 billion, followed by health care giant <a href=\"https://ttm.financial/S/UNH\">$UnitedHealth(UNH)$</a> with a market capitalization of about $482 billion, And the $470 billion Danish drug","listText":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> leads the pack with a market cap of $610 billion, followed by health care giant <a href=\"https://ttm.financial/S/UNH\">$UnitedHealth(UNH)$</a> with a market capitalization of about $482 billion, And the $470 billion Danish drug","text":"The healthcare sector has plenty of innovative companies that have created massive wealth for investors, but so far, none of the healthcare companies in the US have reached a market cap of $1 trillion. That's understandable since the \"trillion-dollar club\" in the US is pretty exclusive and is dominated by a few tech giants.However, it's only a matter of time before a healthcare company joins the club, and who will be the lucky one?Meet the Top 5 candidates in my heart for the trillion-dollar healthcare stock: $Eli Lilly(LLY)$ leads the pack with a market cap of $610 billion, followed by health care giant $UnitedHealth(UNH)$ with a market capitalization of about $482 billion, And the $470 billion Danish drug","images":[{"img":"https://community-static.tradeup.com/news/2a361d23ecf16ad5423ccee7ca5a7b43","width":"1280","height":"720"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":2189,"commentSize":5,"repostSize":644,"link":"https://ttm.financial/post/266562335506688","isVote":1,"tweetType":1,"viewCount":15771,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4087650318161980","authorId":"4087650318161980","name":"ahBern","avatar":"https://static.tigerbbs.com/88263929bb1a9cc8c5ea90409c5bd436","crmLevel":3,"crmLevelSwitch":1},"content":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","html":"Great ariticle, would you like to share it?"}],"imageCount":2,"langContent":"EN","totalScore":0},{"id":269729708081168,"gmtCreate":1706876492444,"gmtModify":1707122633604,"author":{"id":"4144906086863692","authorId":"4144906086863692","name":"NAI500","avatar":"https://community-static.tradeup.com/news/01a5cfb1c65c21d31f28a3934107c034","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Amgen - a premium healthcare dividend stock with stable cash flow","htmlText":"Compared to other dividend stocks like REITs, the dividend yield from a company like <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","listText":"Compared to other dividend stocks like REITs, the dividend yield from a company like <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, <a href=\"https://ttm.financial/S/AMGN\">$Amgen(AMGN)$</a> is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","text":"Compared to other dividend stocks like REITs, the dividend yield from a company like $Amgen(AMGN)$ might not seem as impressive at first glance, but it has the advantage of being less risky and more secure. A good healthcare dividend stock is one that has the resources and capabilities to survive for a long time, while also generating enough profits to pay dividends to shareholders.If you want to learn more about the characteristics of premium healthcare dividend stocks, $Amgen(AMGN)$ is a great research sample.Monthly chartAmgen, one of the leading biopharmaceutical companies, has the ability to generate stable cash flow! Here's why:Firstly, the company has a diversified product portfolio. Its products s","images":[{"img":"https://community-static.tradeup.com/news/a23f302bf567521fec5d27e46a04ef6d","width":"560","height":"240"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":488,"commentSize":4,"repostSize":48,"link":"https://ttm.financial/post/269729708081168","isVote":1,"tweetType":1,"viewCount":2802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":269908004597776,"gmtCreate":1706920021867,"gmtModify":1707122633476,"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Q: What is Eli Lilly 2023/Q4 Earnings Preview?","htmlText":"<a href=\"https://ttm.financial/gpt\">TigerGPT</a> Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","listText":"<a href=\"https://ttm.financial/gpt\">TigerGPT</a> Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","text":"TigerGPT Answer: 【Forecast Data】 Eli Lilly and Co (LLY) is expected to report the following financial forecast data for this quarter: - Earnings Per Share (EPS): $2.19 - Total Revenue: $8,932,335,750.00 - EBIT: $2,222,732,560.00 Compared to the same period last year: - EPS has increased by 4.78% from $2.09. - Total Revenue has increased by 22.46% from $7,301,800,000.00. - EBIT has increased by 11.21% from $1,998,600,000.00. The significance of these changes indicates that Eli Lilly is experiencing growth in profitability, revenue, and operational efficiency. 【Quarterly Important News】 Key news over the past quarter includes: - The U.S. government's preliminary proposal for significant price reductions on 10 high-cost drugs, which could impact reve","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/269908004597776","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":270470812565520,"gmtCreate":1707057426156,"gmtModify":1707132076751,"author":{"id":"4144906086863692","authorId":"4144906086863692","name":"NAI500","avatar":"https://community-static.tradeup.com/news/01a5cfb1c65c21d31f28a3934107c034","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Can Novavax help investors become millionaires?","htmlText":"图片<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","listText":"图片<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","text":"图片$Novavax(NVAX)$ stock might have created some millionaires in 2020. It was at the peak of the COVID-19 vaccine race, and investors were betting on this biotech company to cross the finish line. That year, the stock surged 2700%, and if you locked in those gains and invested $40,000 in the stock, you might have become a millionaire.Since then, Novavax shares have fallen more than 90% from their peak. The company disappointed investors by failing to reach the finish line for COVID-19 vaccine production in time and missing its biggest revenue opportunity. That's why Novavax launched a cost-cutting strategy last year, and even given some uncertainty, the company expressed concerns about its ability to continue operations.But there are some bright sp","images":[{"img":"https://community-static.tradeup.com/news/0b9d779cc9ff4b8158915ee5f25df5c1","width":"902","height":"557"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/270470812565520","isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":268303618764872,"gmtCreate":1706523464890,"gmtModify":1707122633525,"author":{"id":"3527667626267411","authorId":"3527667626267411","name":"Value_investing","avatar":"https://community-static.tradeup.com/news/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":0,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Lilly becomes the winner when investors turns to weight loss drugs","htmlText":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> 's market value has lost $80 billion, so <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","listText":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> 's market value has lost $80 billion, so <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","text":"图片Weight loss drug innovators have replaced electric car manufacturers as one of the must-buy stocks for 2024. Due to investors' concerns about slowing earnings growth, $Tesla Motors(TSLA)$ 's market value has lost $80 billion, so $Eli Lilly(LLY)$ 's market value surpassed Tesla on January 25th.Lilly is the latest company to have a market value that surpasses Tesla, signaling a shift in investor interest. Electric car manufacturers and suppliers are no longer bought by investors due to the promise of large-scale adoption of electric vehicles. Instead, weight loss drugs have become popular.Lilly's stock has soared due to the promising prospects of Mounjaro and Zepbound, which have made it the world's larges","images":[{"img":"https://community-static.tradeup.com/news/5bba35399199a6abee026b7770fe78a9","width":"719","height":"461"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":66,"commentSize":1,"repostSize":7,"link":"https://ttm.financial/post/268303618764872","isVote":1,"tweetType":1,"viewCount":769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":269377699418120,"gmtCreate":1706790651828,"gmtModify":1707122633500,"author":{"id":"3527667668165440","authorId":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Healthcare Giants NVO & LLY Eye Trillion-Dollar Club","htmlText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","listText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","text":"The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","images":[{"img":"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e","width":"1540","height":"705"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":472,"commentSize":2,"repostSize":72,"link":"https://ttm.financial/post/269377699418120","isVote":1,"tweetType":1,"viewCount":2628,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274781763777","authorId":"3479274781763777","name":"tothehill","avatar":"https://static.laohu8.com/picture118","crmLevel":1,"crmLevelSwitch":0},"content":"Hilarious market potential! 😂 Agree! 🙌","text":"Hilarious market potential! 😂 Agree! 🙌","html":"Hilarious market potential! 😂 Agree! 🙌"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":268946265260032,"gmtCreate":1706681476872,"gmtModify":1707122633559,"author":{"id":"9000000000000369","authorId":"9000000000000369","name":"TrendSpider","avatar":"https://community-static.tradeup.com/news/735481e1e3ac7d7e59d7f9448b31b8a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Trend Charts: GOOG, PYPL, ARKK, LLY, BABA, AMD& TSLA","htmlText":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for <a href=\"https://ttm.financial/S/COST\">$Costco(COST)$</a> as price cracks the $700 mark... When stock split?ImageARK Innovation Update <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> Cathie Wood now owns $615M of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> in the <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image <a href=\"https://ttm.financial/S/PYPL\">$PayPal(PYPL)$</a> flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","listText":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for <a href=\"https://ttm.financial/S/COST\">$Costco(COST)$</a> as price cracks the $700 mark... When stock split?ImageARK Innovation Update <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> Cathie Wood now owns $615M of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> in the <a href=\"https://ttm.financial/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image <a href=\"https://ttm.financial/S/PYPL\">$PayPal(PYPL)$</a> flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","text":"Hello everyone! Today I want to share some potential stocks with you! Hope it can help you!The stocks are as follow:New ATHs for $Costco(COST)$ as price cracks the $700 mark... When stock split?ImageARK Innovation Update $ARK Innovation ETF(ARKK)$ Cathie Wood now owns $615M of $Tesla Motors(TSLA)$ in the $ARK Innovation ETF(ARKK)$ ETF. This makes Tesla the third largest holding, representing nearly 8% of the entire fund.Image $PayPal(PYPL)$ flips green, now up +0.85% after announcing plans to cut least 2,000 employees. Is this what the CEO meant by shocking the world?Image","images":[{"img":"https://community-static.tradeup.com/news/c0659081d0a154c848a2a2c54aabe504","width":"1128","height":"726"},{"img":"https://community-static.tradeup.com/news/a5815dcd968bfb6df3ce5e56347217b1","width":"1128","height":"726"},{"img":"https://community-static.tradeup.com/news/1151b1f125124a4ecea022537e66aa29","width":"1128","height":"726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":52,"commentSize":1,"repostSize":3,"link":"https://ttm.financial/post/268946265260032","isVote":1,"tweetType":1,"viewCount":1766,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274777284002","authorId":"3479274777284002","name":"uuunited","avatar":"https://static.laohu8.com/picture108","crmLevel":1,"crmLevelSwitch":0},"content":"LOL, I agree with the potential stocks! 🚀","text":"LOL, I agree with the potential stocks! 🚀","html":"LOL, I agree with the potential stocks! 🚀"}],"imageCount":8,"langContent":"EN","totalScore":0},{"id":271068192170000,"gmtCreate":1707203270786,"gmtModify":1707203274164,"author":{"id":"9000000000000420","authorId":"9000000000000420","name":"PorterLamb","avatar":"https://static.tigerbbs.com/9c61226b13dc84ab3139a9fa00b20782","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","text":"$Eli Lilly(LLY)$ I own LLY, but a word of caution before purchasing at these prices. On 12/14/2023 Mounjaro was approved by the FDA and LLY was down around ~7% midday. It took about two weeks for the price to recover.I am concerned that this may be happening on a much larger scale this time. A run up of 9% before earnings seems like an incredible amount. It may not matter what happens with the earnings and call. There is likely to be profit taking. It doesn't help that 5 analysts have revised their forecasts downward in the last month. This could be due to manufacturing constraints, but I guess we'll find out tomorrow morning.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068192170000","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271320697122824,"gmtCreate":1707265016503,"gmtModify":1707271656380,"author":{"id":"4120382896042882","authorId":"4120382896042882","name":"DavidMarlin","avatar":"https://community-static.tradeup.com/news/4f415c3ff5550e60135034b2936557a9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"NVDA could see upside to $1100+","htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$</a> could see upside to $1100+ if it continues mirroring the trajectory of <a href=\"https://ttm.financial/S/CSCO\">$Cisco(CSCO)$</a> during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$</a> could see upside to $1100+ if it continues mirroring the trajectory of <a href=\"https://ttm.financial/S/CSCO\">$Cisco(CSCO)$</a> during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","text":"$NVIDIA Corp(NVDA)$ could see upside to $1100+ if it continues mirroring the trajectory of $Cisco(CSCO)$ during the Dot Com Bubble.ImageIs NVDA the new CSCO of its time?If this continues to track, Nvidia would need to reach all the way to 1100. Then, it would take a 23-year nap before seeing that high again.Imagehttps://twitter.com/Marlin_Capital/status/1754922707307614606/photo/1","images":[{"img":"https://community-static.tradeup.com/news/92db78f6c26b912544295d46418a99ff","width":"1918","height":"1147"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/271320697122824","isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},{"id":271067166711824,"gmtCreate":1707203020430,"gmtModify":1707203027192,"author":{"id":"9000000000000494","authorId":"9000000000000494","name":"MamieBenson","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","text":"$Eli Lilly(LLY)$ LLY should open around $730 tomorrow then we will see how high it will run before a stall for a breath before taking the long climb continuing higher. Unloaded a few more shares into the close today. Still hold some, may get out entirely if there is an irrational earnings pop. I've made SO much money in the stock...but there's definitely some very irrational FOMO going on.","images":[{"img":"https://community-static.tradeup.com/news/a0eff104dcee9b096d48ca67e5d92cef","width":"367","height":"300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271067166711824","isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":271068527988744,"gmtCreate":1707203451772,"gmtModify":1707204068162,"author":{"id":"9000000000000640","authorId":"9000000000000640","name":"DaisyMoore","avatar":"https://static.tigerbbs.com/0b6d4586dc3002807c92bc57e1b3a6bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","text":"$Eli Lilly(LLY)$ This is insane. I purchased 1500 shares in this back in 2013 because I was involved in one of their drug trials and I figured why not. Turns out my position is now worth a little over 1.25 million, including some of the dividends reinvested, but only a small fraction. The return has been amazingWhat has been going on here? This is just not a stock I followed up much with since it is in a retirement acct.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068527988744","isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271068694966288,"gmtCreate":1707203393539,"gmtModify":1707203396671,"author":{"id":"9000000000000524","authorId":"9000000000000524","name":"KarenAldridge","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"1\"></v-v> You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","text":"$Eli Lilly(LLY)$ You can't use PE to get an accurate valuation on pharmaceutical companies. Sure, PFE is popular with retail investors because of the dividend. You need to use forecasted revenue because of the nature of the drug industry. Patents expire. So if you don't have anything in the pipeline... *PFE*... then the stock goes into a death spiral. LLY has a strong pipeline on top of tirzepatide.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271068694966288","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271067102011400,"gmtCreate":1707203103633,"gmtModify":1707203107483,"author":{"id":"9000000000000463","authorId":"9000000000000463","name":"MurrayBulwer","avatar":"https://static.tigerbbs.com/86339b64cf42eeac7905c45fdbbed7fb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> <v-v data-views=\"0\"></v-v> I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","text":"$Eli Lilly(LLY)$ I have a $600 call option expiring January 2025.. I’d love for this to go parabolic tomorrow like anyone else. However, I don’t think this holds — chances are, the time to get out was today at close. There are so many times companies run up into earnings and crater soon thereafter. It’s like clockwork.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271067102011400","isVote":1,"tweetType":1,"viewCount":31,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":271266406834384,"gmtCreate":1707265059399,"gmtModify":1707265064283,"author":{"id":"4165616159265732","authorId":"4165616159265732","name":"Mangoman","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;[Smile]&nbsp;&nbsp;","text":"[Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/271266406834384","isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":270882760790256,"gmtCreate":1707171457450,"gmtModify":1707171462512,"author":{"id":"3579087512632846","authorId":"3579087512632846","name":"Warrior388","avatar":"https://static.tigerbbs.com/51833ad468f8a1ea4c6681fe3c76c453","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Yes, no doubt of it, another nvda in phama sector.","listText":"Yes, no doubt of it, another nvda in phama sector.","text":"Yes, no doubt of it, another nvda in phama sector.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/270882760790256","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}]}